Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
出版年份 2009 全文链接
标题
Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 8, Issue 8, Pages 977-986
出版商
Informa UK Limited
发表日期
2009-07-23
DOI
10.1586/erv.09.68
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007
- (2009) Jae-Hoon Song et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007
- (2009) A. Fenoll et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Introduction and Proliferation of Multidrug‐ResistantStreptococcus pneumoniaeSerotype 19A Clones That Cause Acute Otitis Media in an Unvaccinated Population
- (2009) Ron Dagan et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
- (2009) Heather E. Hsu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome
- (2009) Simon Rückinger et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines
- (2009) Gail L. Rodgers et al. VACCINE
- Challenges in the evaluation and licensing of new pneumococcal vaccines, 7–8 July 2008, Ottawa, Canada
- (2009) I. Feavers et al. VACCINE
- Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of Faropenem
- (2008) I. A. Critchley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Temporal and Spatial Distribution of Clonal Complexes of Streptococcus pneumoniae Isolates Resistant to Multiple Classes of Antibiotics in Belgium, 1997 to 2004
- (2008) H. Amrine-Madsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changing Epidemiology of Antimicrobial‐ResistantStreptococcus pneumoniaein the United States, 2004–2005
- (2008) Sandra S. Richter et al. CLINICAL INFECTIOUS DISEASES
- Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era
- (2008) Ener Cagri Dinleyici et al. Expert Review of Vaccines
- Population Snapshot of Streptococcus pneumoniae Serotype 19A Isolates before and after Introduction of Seven-Valent Pneumococcal Vaccination for French Children
- (2008) F. Mahjoub-Messai et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pneumococcal disease in a paediatric population in a hospital of central Italy: A clinical and microbiological case series from 1992 to 2006
- (2008) Francesca Montagnani et al. JOURNAL OF INFECTION
- Age‐ and Serotype‐Specific Pediatric Invasive Pneumococcal Disease: Insights from Systematic Surveillance in Santiago, Chile, 1994–2007
- (2008) Rosanna Lagos et al. JOURNAL OF INFECTIOUS DISEASES
- Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005
- (2008) Matthew R. Moore et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of conjugate pneumococcal vaccines on antibiotic resistance
- (2008) Ron Dagan et al. LANCET INFECTIOUS DISEASES
- Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997-2004
- (2008) F. Zhou et al. PEDIATRICS
- Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults
- (2008) Daniel Scott et al. PEDIATRICS INTERNATIONAL
- Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine
- (2007) C. Munoz-Almagro et al. CLINICAL INFECTIOUS DISEASES
- Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era
- (2007) S. Nunes et al. CLINICAL MICROBIOLOGY AND INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started